Prognostic role of preoperative carcinoembryonic antigen levels in colorectal cancer: propensity score matching
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study was conducted to investigate preoperative carcinoembryonic antigen (CEA) as a prognostic factor in colorectal cancer. Methods: Between January 2000 and July 2011, 1298 patients with primary adenocarcinoma colorectal cancer without metastasis, who underwent curative resection were retrospectively identified. The patients were divided into two groups according to serum CEA level at primary diagnosis: a high CEA (HCEA) group (serum CEA ≥6 ng/mL) and a normal CEA (NCEA) group (serum CEA <6 ng/mL). A 1:1 propensity score matching analysis was applied to reduce bias. Finally, 364 patients were enrolled in this study. Matched variables were age, gender, preoperative chemoradiotherapy, tumor site, cell differentiation and pathologic stage. Results: The clinicopathological characteristics of the two groups did not differ significantly difference. The systemic metastasis rate was 16.5% (30/182) and 25.3% (46/182) in the NCEA and HCEA groups, respectively (p=0.039). There were no significant differences in local recurrence or metastatic sites between groups. The 5-year disease-free survival (DFS) rate of the HCEA group was worse than that of the NCEA group; however, there was no significant difference in overall survival between the two groups. Conclusion: Elevated preoperative CEA was related to frequent systemic recurrence and low DFS. Therefore, elevated preoperative CEA could be considered a prognostic factor for worse clinical outcomes in patients with colorectal cancer
Abstract
Background: This study was conducted to investigate preoperative carcinoembryonic antigen (CEA) as a prognostic factor in colorectal cancer. Methods: Between January 2000 and July 2011, 1298 patients with primary adenocarcinoma colorectal cancer without metastasis, who underwent curative resection were retrospectively identified. The patients were divided into two groups according to serum CEA level at primary diagnosis: a high CEA (HCEA) group (serum CEA ≥6 ng/mL) and a normal CEA (NCEA) group (serum CEA <6 ng/mL). A 1:1 propensity score matching analysis was applied to reduce bias. Finally, 364 patients were enrolled in this study. Matched variables were age, gender, preoperative chemoradiotherapy, tumor site, cell differentiation and pathologic stage. Results: The clinicopathological characteristics of the two groups did not differ significantly difference. The systemic metastasis rate was 16.5% (30/182) and 25.3% (46/182) in the NCEA and HCEA groups, respectively (p=0.039). There were no significant differences in local recurrence or metastatic sites between groups. The 5-year disease-free survival (DFS) rate of the HCEA group was worse than that of the NCEA group; however, there was no significant difference in overall survival between the two groups. Conclusion: Elevated preoperative CEA was related to frequent systemic recurrence and low DFS. Therefore, elevated preoperative CEA could be considered a prognostic factor for worse clinical outcomes in patients with colorectal cancer
참고문헌 (18)
- Wang JY, "Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer", Eur Surg Res, 39, pp.245~250 (2007)
- Becerra AZ, "Evaluating the prognostic role of elevated preoperative carcinoembryonic antigen levels in colon cancer patients: results from the National Cancer Database", Ann Surg Oncol, 23, pp.1554~1561 (2016)
- Goldstein MJ, "Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer", Cancer Invest, 23, pp.338~351 (2005)
- Moertel CG, "The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer", Cancer, 58, pp.603~610 (1986)
- Ozawa H, "Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer", Int J Colorectal Dis, 32, pp.821~829 (2017)
- Park IJ, "Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level", Ann Surg Oncol, 16, pp.3087~3093 (2009)
- Compton CC, "Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999", Arch Pathol Lab Med, 124, pp.979~994 (2000)
- Carriquiry LA, "Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?", Dis Colon Rectum, 42, pp.921~929 (1999)
- Duffy MJ, "Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?", Clin Chem, 47, pp.624~630 (2001)
- Bhatnagar J, "Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer", Anticancer Res, 19, pp.2181~2187 (1999)
- Slater G, "Preoperative carcinoembryonic antigen levels in colorectal carcinoma", Arch Surg, 114, pp.52~53 (1979)
- Park YA, "Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer", Ann Surg Oncol, 13, pp.645~650 (2006)
- Huh JW, "Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer", J Surg Oncol, 101, pp.396~400 (2010)
- Kim CG, "Preoperative serum carcinoembryonic antigen level as a prognostic factor for recurrence and survival after curative resection followed by adjuvant chemotherapy in stage III colon cancer", Ann Surg Oncol, 24, pp.227~235 (2017)
- Kirat HT, "The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer", Am J Surg, 204, pp.447~452 (2012)
- Takagawa R, "Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer", Ann Surg Oncol, 15, pp.3433~3439 (2008)
- Gunderson LL, "Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis", J Clin Oncol, 22, pp.1785~1796 (2004)
- Fukuda I, "Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services", J Med Syst, 22, pp.89~93 (1998)